Sorafenib in Relapsed High Grade Osteosarcoma

Clinical Trial ID NCT00889057

PubWeight™ 3.15‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00889057

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int 2016 0.81
2 Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment. Clin Sarcoma Res 2012 0.81
3 Future directions in the treatment of osteosarcoma. Curr Opin Pediatr 2016 0.79
4 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100